Phototherapy in dermatology: A call for action

Henry W. Lim; Narumol Silpa-Archa; Ugochukwu Amadi; Alan Menter; Abby S. Van Voorhees; Mark Lebwohl

doi:10.1016/j.jaad.2015.03.017

Phototherapy in dermatology: A call for action

Henry W. Lim, Narumol Silpa-Archa, Ugochukwu Amadi, Alan Menter, Abby S. Van Voorhees, Mark Lebwohl

Research output: Contribution to journal › Editorial

58 Scopus citations

Abstract

Of the wide range of treatment modalities available to dermatologists, few possess the history, efficacy, and safety of phototherapy. It should be emphasized that dermatologists are the only group of physicians optimally trained and qualified to understand the medical indications of phototherapy. Phototherapy, recognized for its cost-effectiveness, should remain a consideration in patient treatment. Continued training and education in residency and thereafter is needed to maintain the proficiency of physicians. In addition, payors need continued education to ensure that insurance coverage of phototherapy is not a barrier for patients to access this therapy. To further improve and optimize the outcome, phototherapy research needs to be supported.

Original language	English
Pages (from-to)	1078-1080
Number of pages	3
Journal	Journal of the American Academy of Dermatology
Volume	72
Issue number	6
DOIs	https://doi.org/10.1016/j.jaad.2015.03.017
State	Published - 1 Jun 2015

Keywords

biologics
cost-effectiveness
cutaneous diseases
narrowband ultraviolet B
phototherapy
psoralen plus ultraviolet A
psoriasis
ultraviolet A1

Access to Document

10.1016/j.jaad.2015.03.017

Cite this

@article{0c00f29572a7433aa3aa1fa435e1a5e1,

title = "Phototherapy in dermatology: A call for action",

abstract = "Of the wide range of treatment modalities available to dermatologists, few possess the history, efficacy, and safety of phototherapy. It should be emphasized that dermatologists are the only group of physicians optimally trained and qualified to understand the medical indications of phototherapy. Phototherapy, recognized for its cost-effectiveness, should remain a consideration in patient treatment. Continued training and education in residency and thereafter is needed to maintain the proficiency of physicians. In addition, payors need continued education to ensure that insurance coverage of phototherapy is not a barrier for patients to access this therapy. To further improve and optimize the outcome, phototherapy research needs to be supported.",

keywords = "biologics, cost-effectiveness, cutaneous diseases, narrowband ultraviolet B, phototherapy, psoralen plus ultraviolet A, psoriasis, ultraviolet A1",

author = "Lim, {Henry W.} and Narumol Silpa-Archa and Ugochukwu Amadi and Alan Menter and {Van Voorhees}, {Abby S.} and Mark Lebwohl",

note = "Publisher Copyright: {\textcopyright} 2015 American Academy of Dermatology, Inc.",

year = "2015",

month = jun,

day = "1",

doi = "10.1016/j.jaad.2015.03.017",

language = "English",

volume = "72",

pages = "1078--1080",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Phototherapy in dermatology

T2 - A call for action

AU - Lim, Henry W.

AU - Silpa-Archa, Narumol

AU - Amadi, Ugochukwu

AU - Menter, Alan

AU - Van Voorhees, Abby S.

AU - Lebwohl, Mark

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Of the wide range of treatment modalities available to dermatologists, few possess the history, efficacy, and safety of phototherapy. It should be emphasized that dermatologists are the only group of physicians optimally trained and qualified to understand the medical indications of phototherapy. Phototherapy, recognized for its cost-effectiveness, should remain a consideration in patient treatment. Continued training and education in residency and thereafter is needed to maintain the proficiency of physicians. In addition, payors need continued education to ensure that insurance coverage of phototherapy is not a barrier for patients to access this therapy. To further improve and optimize the outcome, phototherapy research needs to be supported.

AB - Of the wide range of treatment modalities available to dermatologists, few possess the history, efficacy, and safety of phototherapy. It should be emphasized that dermatologists are the only group of physicians optimally trained and qualified to understand the medical indications of phototherapy. Phototherapy, recognized for its cost-effectiveness, should remain a consideration in patient treatment. Continued training and education in residency and thereafter is needed to maintain the proficiency of physicians. In addition, payors need continued education to ensure that insurance coverage of phototherapy is not a barrier for patients to access this therapy. To further improve and optimize the outcome, phototherapy research needs to be supported.

KW - biologics

KW - cost-effectiveness

KW - cutaneous diseases

KW - narrowband ultraviolet B

KW - phototherapy

KW - psoralen plus ultraviolet A

KW - psoriasis

KW - ultraviolet A1

UR - http://www.scopus.com/inward/record.url?scp=84929629863&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2015.03.017

DO - 10.1016/j.jaad.2015.03.017

M3 - Editorial

C2 - 25981004

AN - SCOPUS:84929629863

SN - 0190-9622

VL - 72

SP - 1078

EP - 1080

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -

Phototherapy in dermatology: A call for action

Abstract

Keywords

Access to Document

Fingerprint

Cite this